Renin‐Angiotensin‐Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal Aneurysm Repair

Author:

Elsayed Nadin1,Gaffey Ann C.1,Abou‐Zamzam Ahmed2,Malas Mahmoud B.1ORCID

Affiliation:

1. Division of Vascular and Endovascular Surgery, Department of Surgery University of California San Diego La Jolla CA USA

2. Department of Surgery, Division of Vascular Surgery Loma Linda University Medical Center Loma Linda CA USA

Abstract

Background The best medical therapy to control hypertension following abdominal aortic aneurysm repair is yet to be determined. We therefore examined whether treatment with renin‐angiotensin‐aldosterone system inhibitors (RAASIs) versus beta blockers influenced postoperative and 1‐year clinical end points following abdominal aortic aneurysm repair in a Medicare‐linked database. Methods and Results All patients with hypertension undergoing endovascular aneurysm repair and open aneurysm repair in the Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database between 2003 and 2018 were included. Patients were divided into 2 groups based on their preoperative and discharge medications, either RAASIs or beta blockers. Our cohort included 8789 patients, of whom 3523 (40.1%) were on RAASIs, and 5266 (59.9%) were on beta blockers. After propensity score matching, there were 3053 matched pairs of patients in each group. After matching, RAASI use was associated with lower risk of postoperative mortality (odds ratio [OR], 0.3 [95% CI, 0.1–0.6]), myocardial infarction (OR, 0.1 [95% CI, 0.03–0.6]), and nonhome discharge (OR, 0.6 [95% CI, 0.5–0.7]). Before propensity score matching, RAASI use was associated with lower 1‐year mortality (hazard ratio [HR], 0.4 [95% CI, 0.4–0.5]) and lower risk of aneurysmal rupture (HR, 0.7 [95% CI, 0.5–0.9]). These results persisted after propensity score matching for mortality (HR, 0.4 [95% CI, 0.4–0.5]) and aneurysmal rupture (HR, 0.7 [95% CI, 0.5–0.9]). Conclusions In this large contemporary retrospective cohort study, RAASI use was associated with favorable postoperative outcomes compared with beta blockers. It was also associated with lower mortality and aneurysmal rupture at 1 year of follow‐up.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3